NIH-funded research R01 grant

Investigating how a specific receptor affects heart function in people with high blood pressure

Official title: Mineralocorticoid receptor, coronary microvascular function, and cardiac efficiency in hypertension

Funded at Brigham and Women's Hospital · NIH-11001139 · Data updated 2026-11-12

This study is looking at how certain receptors in the body affect heart health in people with high blood pressure and thickened heart muscles, and it will help us understand if blocking these receptors can improve heart function and overall health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2026
Funding year2025
Award (this year)$698,386
NIH project number5R01HL162960-03
Project IDNIH-11001139 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults with hypertension and left ventricular hypertrophy who are currently on ACE inhibitors.

Less likely to help

Patients without hypertension or those who do not have left ventricular hypertrophy may not benefit from this research.

What this research studies

This research explores the relationship between mineralocorticoid receptors and heart function in individuals with hypertension and left ventricular hypertrophy. It aims to understand how these receptors influence coronary microvascular function and cardiac efficiency, which are critical for heart health. Participants will be randomly assigned to receive either a treatment that blocks these receptors or a control, allowing researchers to assess the impact on heart function and overall cardiovascular outcomes. The study is designed to fill a significant gap in current treatments for coronary microvascular dysfunction and abnormal cardiac efficiency.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options that improve heart function and reduce cardiovascular risks for patients with hypertension.

How similar studies have gone: Previous research has indicated that targeting mineralocorticoid receptors may improve cardiovascular outcomes, suggesting potential success for this approach.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Adler, Gail Kurr — Brigham and Women's Hospital
  • Study coordinator: Adler, Gail Kurr

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.